CheckMate 649: Nivolumab plus chemotherapy for gastric and oesophageal cancers
CheckMate 649: Nivolumab plus chemotherapy for gastric and oesophageal cancers
AMG 160: A PSMA-targeted, bispecific T-cell engager immune therapy for mCRPC
LungART: Radiotherapy after surgery for patients with non small cell lung cancer
SOLO-1: Olaparib or placebo for patients with newly diagnosed BRCA-mutated advanced ovarian cancer
Pembrolizumab vs cetuximab with radiotherapy in locally advanced HNSCC
The emerging importance of studying immune regulatory molecule expression patterns
OncoAlert and ecancer weekly roundup for September 6-13, 2020
Fundamentals of nanoparticles in cancer immunotherapy and radiotherapy
OncoAlert and ecancer weekly roundup for August 24-29 2020
OncoAlert and ecancer weekly roundup for August 17-23 2020
OncoAlert and ecancer weekly roundup for August 1-8 2020
Direction and reasoning behind the AORTIC African Cancer Dialogues